Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Rā whakaputa: | 2020 |
| Hōputu: | Doctoral thesis |
| Reo: | por |
| Puna: | Repositório Institucional da UFG |
| Download full: | http://repositorio.bc.ufg.br/tede/handle/tede/11239 |
Whakarāpopototanga: | Toxoplasmosis is characterized by a protozoosis caused by Toxoplasma gondii (T. gondii). It is a disease that causes a great impact on human health due to its high risk of vertical transmission and fetal involvement, which can compromise the health and development of the baby, before or after birth. Of great impact on human health, toxoplasmosis requires screening, diagnosis and appropriate treatment to avoid or minimize its potential damage. The objective of this study was to quantify the prevalence of toxoplasmosis in pregnant women in the municipality of Gurupi-TO and to compare the effectiveness of spiramycin in the treatment of the congenital form of the disease, as well as the sequelae existing in infected neonates. A descriptive, epidemiological, observational and cross-sectional study was carried out, in which 309 medical records of pregnant women monitored in Basic Health Units in Gurupi-Tocantins from 2010 to 2017 were analyzed, in order to describe the seroepidemiology of the disease. 30 medical records of pregnant women treated with different medication regimens were also analyzed, investigating the children's serology after birth and the presence or absence of sequelae related to congenital toxoplasmosis. Regarding sociodemographic characteristics, it was observed that the majority of pregnant women, 58.57 %% (n = 181) were between 20 and 30 years old, 172 (55.6%) were married, 55.0% (n = 170) had one or two pregnancies and 66.0% (204) were between the first and the second trimester of pregnancy. Analyzing the results of serology for toxoplasmosis, it was observed that the prevalence for gestational toxoplasmosis was 30.1% (n = 93), and in 16.12% (n = 50) of the records analyzed, the result of serology has not been demonstrated and in 20.7% (n = 64) of women, T. gondii infection was active or recent. The positive impact of continued treatment throughout the pregnancy was observed since of the 15 children, children of mothers who were treated during the whole pregnancy with spiramycin, only 1 had positive serology for toxoplasmosis after birth. On the other hand, of the 15 children gestated by the mothers who belonged to the group of pregnant women who were treated with spiramycin for only 2 months after the diagnosis of the disease, in which 13 babies presented positive serology, indicating congenital toxoplasmosis. The most frequent sequelae observed in these children were: chorioretinitis (80%) and delayed motor development (53%). These findings show that Gurupi-TO was shown to be a municipality with a high endemicity of this parasite, resulting in a warning signal both for the number of toxoplasma infections during pregnancy as well as for the high number of pregnant women susceptible to infection. It is also noteworthy that the continued prenatal treatment for toxoplasmosis with the use of spiramycin proved to be a strong ally in preventing sequelae in children in this population after birth. |
| _version_ | 1871426366956634112 |
|---|---|
| author | Sousa, Sara Falcão de |
| author_browse | Sousa, Sara Falcão de |
| author_facet | Sousa, Sara Falcão de |
| author_role | author |
| bitstream.checksum.fl_str_mv | 8a4605be74aa9ea9d79846c1fba20a33 4460e5956bc1d1639be9ae6146a50347 610596faa8861324745f9b9fe7e0f6af |
| bitstream.checksumAlgorithm.fl_str_mv | MD5 MD5 MD5 |
| bitstream.url.fl_str_mv | http://repositorio.bc.ufg.br/tede/bitstreams/21357624-cf3c-4915-bff1-84075c8ba1ee/download http://repositorio.bc.ufg.br/tede/bitstreams/4d18ff6a-0130-41d2-98b4-18ff005f5444/download http://repositorio.bc.ufg.br/tede/bitstreams/c92b818b-4ea6-4a27-b0d5-3aa60af04cb4/download |
| collection | Repositório Institucional da UFG |
| contributor_str_mv | Sousa, Ana Luiza Lima Sousa, Ana Luiza Lima D’ Alessandro, Walmirton Bezerra Gontijo, Érica Eugênio Lourenço Garciazapata, Marco Tulio Antonio Silva, Marcos Gontijo da |
| dc.contributor.advisor1.fl_str_mv | Sousa, Ana Luiza Lima |
| dc.contributor.advisor1Lattes.fl_str_mv | http://lattes.cnpq.br/6578713509935374 |
| dc.contributor.author.fl_str_mv | Sousa, Sara Falcão de |
| dc.contributor.authorLattes.fl_str_mv | http://lattes.cnpq.br/1230477171892059 |
| dc.contributor.referee1.fl_str_mv | Sousa, Ana Luiza Lima |
| dc.contributor.referee2.fl_str_mv | D’ Alessandro, Walmirton Bezerra |
| dc.contributor.referee3.fl_str_mv | Gontijo, Érica Eugênio Lourenço |
| dc.contributor.referee4.fl_str_mv | Garciazapata, Marco Tulio Antonio |
| dc.contributor.referee5.fl_str_mv | Silva, Marcos Gontijo da |
| dc.date.accessioned.fl_str_mv | 2021-04-12T14:57:59Z |
| dc.date.available.fl_str_mv | 2021-04-12T14:57:59Z |
| dc.date.issued.fl_str_mv | 2020-07-28 |
| dc.identifier.citation.fl_str_mv | SOUSA, S. F. Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins. 2020. 79 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2020. |
| dc.identifier.uri.fl_str_mv | http://repositorio.bc.ufg.br/tede/handle/tede/11239 |
| dc.language.iso.fl_str_mv | por |
| dc.publisher.country.fl_str_mv | Brasil |
| dc.publisher.department.fl_str_mv | Faculdade de Medicina - FM (RG) |
| dc.publisher.initials.fl_str_mv | UFG |
| dc.publisher.none.fl_str_mv | Universidade Federal de Goiás |
| dc.publisher.program.fl_str_mv | Programa de Pós-graduação em Ciências da Saúde (FM) |
| dc.relation.cnpq.fl_str_mv | 820 |
| dc.relation.confidence.fl_str_mv | 500 500 500 |
| dc.relation.department.fl_str_mv | 19 |
| dc.relation.program.fl_str_mv | 24 |
| dc.rights.driver.fl_str_mv | Attribution-NonCommercial-NoDerivatives 4.0 International info:eu-repo/semantics/openAccess |
| dc.source.none.fl_str_mv | reponame:Repositório Institucional da UFG instname:Universidade Federal de Goiás (UFG) instacron:UFG |
| dc.subject.cnpq.fl_str_mv | CIENCIAS DA SAUDE::MEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICA |
| dc.subject.eng.fl_str_mv | Pregnant women Toxoplasma gondii Therapeutic regimen |
| dc.subject.por.fl_str_mv | Gestantes Toxoplasma gondii Esquema terapêutico |
| dc.title.alternative.eng.fl_str_mv | Prevalence of gestational toxoplasmosis and evaluation of the therapeutic scheme in Gurupi-Tocantins |
| dc.title.pt_BR.fl_str_mv | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins |
| dc.type.driver.fl_str_mv | info:eu-repo/semantics/doctoralThesis |
| dc.type.status.fl_str_mv | info:eu-repo/semantics/publishedVersion |
| description | Toxoplasmosis is characterized by a protozoosis caused by Toxoplasma gondii (T. gondii). It is a disease that causes a great impact on human health due to its high risk of vertical transmission and fetal involvement, which can compromise the health and development of the baby, before or after birth. Of great impact on human health, toxoplasmosis requires screening, diagnosis and appropriate treatment to avoid or minimize its potential damage. The objective of this study was to quantify the prevalence of toxoplasmosis in pregnant women in the municipality of Gurupi-TO and to compare the effectiveness of spiramycin in the treatment of the congenital form of the disease, as well as the sequelae existing in infected neonates. A descriptive, epidemiological, observational and cross-sectional study was carried out, in which 309 medical records of pregnant women monitored in Basic Health Units in Gurupi-Tocantins from 2010 to 2017 were analyzed, in order to describe the seroepidemiology of the disease. 30 medical records of pregnant women treated with different medication regimens were also analyzed, investigating the children's serology after birth and the presence or absence of sequelae related to congenital toxoplasmosis. Regarding sociodemographic characteristics, it was observed that the majority of pregnant women, 58.57 %% (n = 181) were between 20 and 30 years old, 172 (55.6%) were married, 55.0% (n = 170) had one or two pregnancies and 66.0% (204) were between the first and the second trimester of pregnancy. Analyzing the results of serology for toxoplasmosis, it was observed that the prevalence for gestational toxoplasmosis was 30.1% (n = 93), and in 16.12% (n = 50) of the records analyzed, the result of serology has not been demonstrated and in 20.7% (n = 64) of women, T. gondii infection was active or recent. The positive impact of continued treatment throughout the pregnancy was observed since of the 15 children, children of mothers who were treated during the whole pregnancy with spiramycin, only 1 had positive serology for toxoplasmosis after birth. On the other hand, of the 15 children gestated by the mothers who belonged to the group of pregnant women who were treated with spiramycin for only 2 months after the diagnosis of the disease, in which 13 babies presented positive serology, indicating congenital toxoplasmosis. The most frequent sequelae observed in these children were: chorioretinitis (80%) and delayed motor development (53%). These findings show that Gurupi-TO was shown to be a municipality with a high endemicity of this parasite, resulting in a warning signal both for the number of toxoplasma infections during pregnancy as well as for the high number of pregnant women susceptible to infection. It is also noteworthy that the continued prenatal treatment for toxoplasmosis with the use of spiramycin proved to be a strong ally in preventing sequelae in children in this population after birth. |
| eu_rights_str_mv | openAccess |
| format | doctoralThesis |
| id | UFG-2_64737bdfdcd98c442b4d913db2b77fcc |
| identifier_str_mv | SOUSA, S. F. Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins. 2020. 79 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2020. |
| instacron_str | UFG |
| institution | UFG |
| instname_str | Universidade Federal de Goiás (UFG) |
| language | por |
| network_acronym_str | UFG-2 |
| network_name_str | Repositório Institucional da UFG |
| oai_identifier_str | oai:repositorio.bc.ufg.br:tede/11239 |
| publishDate | 2020 |
| publishDateSort | 2020 |
| publisher.none.fl_str_mv | Universidade Federal de Goiás |
| reponame_str | Repositório Institucional da UFG |
| repository.mail.fl_str_mv | grt.bc@ufg.br |
| repository.name.fl_str_mv | Repositório Institucional da UFG - Universidade Federal de Goiás (UFG) |
| repository_id_str | oai:repositorio.bc.ufg.br:tede/1234 |
| rights_invalid_str_mv | Attribution-NonCommercial-NoDerivatives 4.0 International |
| spelling | Sousa, Ana Luiza Limahttp://lattes.cnpq.br/6578713509935374Sousa, Ana Luiza LimaD’ Alessandro, Walmirton BezerraGontijo, Érica Eugênio LourençoGarciazapata, Marco Tulio AntonioSilva, Marcos Gontijo dahttp://lattes.cnpq.br/1230477171892059Sousa, Sara Falcão de2021-04-12T14:57:59Z2021-04-12T14:57:59Z2020-07-28SOUSA, S. F. Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins. 2020. 79 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2020.http://repositorio.bc.ufg.br/tede/handle/tede/11239Toxoplasmosis is characterized by a protozoosis caused by Toxoplasma gondii (T. gondii). It is a disease that causes a great impact on human health due to its high risk of vertical transmission and fetal involvement, which can compromise the health and development of the baby, before or after birth. Of great impact on human health, toxoplasmosis requires screening, diagnosis and appropriate treatment to avoid or minimize its potential damage. The objective of this study was to quantify the prevalence of toxoplasmosis in pregnant women in the municipality of Gurupi-TO and to compare the effectiveness of spiramycin in the treatment of the congenital form of the disease, as well as the sequelae existing in infected neonates. A descriptive, epidemiological, observational and cross-sectional study was carried out, in which 309 medical records of pregnant women monitored in Basic Health Units in Gurupi-Tocantins from 2010 to 2017 were analyzed, in order to describe the seroepidemiology of the disease. 30 medical records of pregnant women treated with different medication regimens were also analyzed, investigating the children's serology after birth and the presence or absence of sequelae related to congenital toxoplasmosis. Regarding sociodemographic characteristics, it was observed that the majority of pregnant women, 58.57 %% (n = 181) were between 20 and 30 years old, 172 (55.6%) were married, 55.0% (n = 170) had one or two pregnancies and 66.0% (204) were between the first and the second trimester of pregnancy. Analyzing the results of serology for toxoplasmosis, it was observed that the prevalence for gestational toxoplasmosis was 30.1% (n = 93), and in 16.12% (n = 50) of the records analyzed, the result of serology has not been demonstrated and in 20.7% (n = 64) of women, T. gondii infection was active or recent. The positive impact of continued treatment throughout the pregnancy was observed since of the 15 children, children of mothers who were treated during the whole pregnancy with spiramycin, only 1 had positive serology for toxoplasmosis after birth. On the other hand, of the 15 children gestated by the mothers who belonged to the group of pregnant women who were treated with spiramycin for only 2 months after the diagnosis of the disease, in which 13 babies presented positive serology, indicating congenital toxoplasmosis. The most frequent sequelae observed in these children were: chorioretinitis (80%) and delayed motor development (53%). These findings show that Gurupi-TO was shown to be a municipality with a high endemicity of this parasite, resulting in a warning signal both for the number of toxoplasma infections during pregnancy as well as for the high number of pregnant women susceptible to infection. It is also noteworthy that the continued prenatal treatment for toxoplasmosis with the use of spiramycin proved to be a strong ally in preventing sequelae in children in this population after birth.A toxoplasmose caracteriza-se por uma protozoose causada pelo Toxoplasma gondii (T. gondii). É uma doença que causa grande impacto na saúde humana devido seu alto risco de transmissão vertical e acometimento fetal, que pode comprometer a saúde e o desenvolvimento do bebê, antes ou após o nascimento. De grande impacto na saúde humana, a toxoplasmose requer triagem, diagnóstico e tratamento adequado para se evitar ou minimizar os seus danos potenciais. O objetivo deste estudo foi quantificar a prevalência de toxoplasmose em gestantes no munício de Gurupi-TO e comparar a efetividade da espiramicina no tratamento da forma congênita da doença, bem como as sequelas existentes nos neonatos infectados. Foi realizado um estudo descritivo, epidemiológico, observacional e transversal, no qual analisou-se 309 prontuários de gestantes acompanhadas em Unidades Básicas de Saúde em Gurupi-Tocantins no período de 2010 a 2017, no intuito de descrever a soroepidemiologia da doença. Também se analisou 30 prontuários de gestantes tratadas com esquemas distintos de medicamentos, em que se investigou a sorologia das crianças após o nascimento e a presença ou não de sequelas relacionadas à toxoplasmose congênita. Com relação às características sociodemográficas, observou-se que a maioria das gestantes, 58,57%% (n=181) possuíam entre 20 e 30 anos de idade, 172 (55,6%) eram casadas, 55,0% (n=170) tiveram uma ou duas gestações e 66,0% (204) estavam entre o primeiro e o segundo trimestre de gestação. Analisando-se os resultados da sorologia para toxoplasmose, observou-se que a prevalência para toxoplasmose gestacional foi de 30,1% (n=93), sendo que em 16,12% (n=50) dos prontuários analisados, o resultado da sorologia não foi demonstrado e em 20,7% (n=64) das mulheres, a infecção por T. gondii estava ativa ou recente. Observou-se o impacto positivo do tratamento continuado durante toda a gestação uma vez que das 15 crianças, filhos de mães que foram tratadas durante toda a gestação com espiramicina, apenas 1 teve sorologia positiva para toxoplasmose após o nascimento. Em contrapartida, das 15 crianças gestadas pelas mães que pertenciam ao grupo de gestantes que foi tratada com espiramicina apenas por 2 meses a partir do diagnóstico da doença, em que 13 bebês apresentaram sorologia positiva, indicando toxoplasmose congênita. As sequelas cuja observação foi mais frequente nessas crianças foram: coriorretinite (80%) e atraso no desenvolvimento motor (53%). Esses achados evidenciam que Gurupi-TO, mostrou-se município com elevada endemicidade deste parasito, resultando em sinal de alerta tanto para o número de infecções por toxoplasma durante a gestação bem como pelo elevado número de mulheres grávidas e susceptíveis à infecção. Ressalta-se ainda que o tratamento pré-natal continuado para toxoplasmose com o uso de espiramicina mostrou-se um forte aliado na prevenção de sequelas nas crianças dessa população após o nascimento.porUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências da Saúde (FM)UFGBrasilFaculdade de Medicina - FM (RG)Attribution-NonCommercial-NoDerivatives 4.0 Internationalinfo:eu-repo/semantics/openAccessGestantesToxoplasma gondiiEsquema terapêuticoPregnant womenToxoplasma gondiiTherapeutic regimenCIENCIAS DA SAUDE::MEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICAPrevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-TocantinsPrevalence of gestational toxoplasmosis and evaluation of the therapeutic scheme in Gurupi-Tocantinsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis2450050050019820reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.bc.ufg.br/tede/bitstreams/21357624-cf3c-4915-bff1-84075c8ba1ee/download8a4605be74aa9ea9d79846c1fba20a33MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8805http://repositorio.bc.ufg.br/tede/bitstreams/4d18ff6a-0130-41d2-98b4-18ff005f5444/download4460e5956bc1d1639be9ae6146a50347MD52ORIGINALTese - Sara Falcão de Sousa - 2020.pdfTese - Sara Falcão de Sousa - 2020.pdfapplication/pdf2792967http://repositorio.bc.ufg.br/tede/bitstreams/c92b818b-4ea6-4a27-b0d5-3aa60af04cb4/download610596faa8861324745f9b9fe7e0f6afMD53tede/112392021-04-12 11:57:59.676http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internationalopen.accessoai:repositorio.bc.ufg.br:tede/11239http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttps://repositorio.bc.ufg.br/tedeserver/oai/requestgrt.bc@ufg.bropendoar:oai:repositorio.bc.ufg.br:tede/12342021-04-12T14:57:59Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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 |
| spellingShingle | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins Sousa, Sara Falcão de Gestantes Toxoplasma gondii Esquema terapêutico Pregnant women Toxoplasma gondii Therapeutic regimen CIENCIAS DA SAUDE::MEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICA |
| status_str | publishedVersion |
| title | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins |
| title_full | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins |
| title_fullStr | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins |
| title_full_unstemmed | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins |
| title_short | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins |
| title_sort | Prevalência da toxoplasmose gestacional e avaliação do esquema terapêutico em Gurupi-Tocantins |
| topic | Gestantes Toxoplasma gondii Esquema terapêutico Pregnant women Toxoplasma gondii Therapeutic regimen CIENCIAS DA SAUDE::MEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICA |
| url | http://repositorio.bc.ufg.br/tede/handle/tede/11239 |